Rhabdastrellic acid-A induced autophagy-Associated cell death through blocking akt pathway in human cancer cells

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Li, Dan Dan ^a   Guo, Jing Feng ^b   Huang, Jia Jia ^a   Wang, Lin Lin ^a   Deng, Rong ^a   Liu, Jian Nan ^a   Feng, Gong Kan ^a   Xiao, Ding Jun ^c   Deng, Song Zhi ^c   Zhang, Xiao Shi ^a   Zhu, Xiao Feng ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c GUANGZHOU INSTITUTE OF CHEMISTRY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; PROTEIN KINASE B; RHABDASTRELLIC ACID A; TRITERPENOID; UNCLASSIFIED DRUG; YELLOW FLUORESCENT PROTEIN; LIGHT CHAIN 3, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; TRITERPENE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOPHAGY; CANCER CELL; CANCER INHIBITION; CELL DEATH; CELL PROLIFERATION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME INHIBITION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KNOCKOUT GENE; MITOSIS INHIBITION; SIGNAL TRANSDUCTION; DRUG EFFECT; GENE EXPRESSION REGULATION; METABOLISM; TUMOR CELL LINE;

RHABDASTRELLA;

AUTOPHAGY; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRITERPENES;

EID: 77957875453     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012176     Document Type: Article

References (40)

1. Liu Y, Mansoor TA, Hong J, Lee CO, Sim CJ, et al. (2003) New cytotoxic sesterterpenoids and norsesterterpenoids from two sponges of the genus Sarcotragus. J Nat Prod 66: 1451-1456.
2. Carroll J, Jonsson EN, Ebel R, Hartman MS, Holman TR, et al. (2001) Probing sponge-derived terpenoids for human 15-lipoxygenase inhibitors. J Org Chem 66: 6847-6851.
3. Rao Z, Deng S, Wu H, Jiang S (1997) Rhabdastrellic Acid-A, a Novel Triterpenoid from the Marine Sponge Rhabdastrella globostellata. J Nat Prod 60: 1163-1164.
4. Guo JF, Zhou JM, Zhang Y, Deng R, Liu JN, et al. (2008) Rhabdastrellic acid-A inhibited PI3K/Akt pathway and induced apoptosis in human leukemia HL-60 cells. Cell Biol Int 32: 48-54.
5. Tasdemir D, Mangalindan GC, Concepcion GP, Verbitski SM, Rabindran S, et al. (2002) Bioactive isomalabaricane triterpenes from the marine sponge Rhabdastrella globostellata. J Nat Prod 65: 210-214.
6. Levine B, Klionsky DJ (2004) Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6: 463-477.
7. Furuya N, Yu J, Byfield M, Pattingre S, Levine B (2005) The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function. Autophagy 1: 46-52.
8. Yuan J, Lipinski M, Degterev A (2003) Diversity in the mechanisms of neuronal cell death. Neuron 40: 401-413.
9. Cuervo AM (2004) Autophagy: in sickness and in health. Trends Cell Biol 14: 70-77.
10. Levine B, Yuan J (2005) Autophagy in cell death: an innocent convict? J Clin Invest 115: 2679-2688.
11. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, et al. (1999) Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402: 672-676.
12. Liang XH, Yu J, Brown K, Levine B (2001) Beclin 1 contains a leucine-rich nuclear export signal that is required for its autophagy and tumor suppressor function. Cancer Res 61: 3443-3449.
13. Chu CT, Zhu J, Dagda R (2007) Beclin 1-independent pathway of damageinduced mitophagy and autophagic stress: implications for neurodegeneration and cell death. Autophagy 3: 663-666.
14. Liang XH, Kleeman LK, Jiang HH, Gordon G, Goldman JE, et al. (1998) Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol 72: 8586-8596.
15. Paglin S, Yahalom J (2006) Pathways that regulate autophagy and their role in mediating tumor response to treatment. Autophagy 2: 291-293.
16. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, et al. (2005) Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120: 237-248.
17. Levine B (2007) Cell biology: autophagy and cancer. Nature 446: 745-747.
18. Mizushima N (2007) Autophagy: process and function. Genes Dev 21: 2861-2873.
19. Yu L, Alva A, Su H, Dutt P, Freundt E, et al. (2004) Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304: 1500-1502.
20. Abdul-Ghani R, Serra V, Gyorffy B, Jurchott K, Solf A, et al. (2006) The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells over expressing MRP1. Oncogene 25: 1743-1752.
21. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, et al. (2004) The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14: 395-403.
22. Cichy SB, Uddin S, Danilkovich A, Guo S, Klippel A, et al. (1998) Protein kinase B/Akt mediates effects of insulin on hepatic insulin-like growth factorbinding protein-1 gene expression through a conserved insulin response sequence. J Biol Chem 273: 6482-6487.
23. Parry R, Smith G, Reif K, Sansom DM, Ward S (1997) Activation of the PI3K effector protein kinase B following ligation of CD28 or Fas. Biochem Soc Trans 25: S589.
24. Franke TF, Kaplan DR, Cantley LC (1997) PI3K: downstream AKTion blocks apoptosis. Cell 88: 435-437.
25. Theodoropoulou M, Zhang J, Laupheimer S, Paez-Pereda M, Erneux C, et al. (2006) Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression. Cancer Res 66: 1576-1582.
26. Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, et al. (2003) Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17: 590-603.
27. Liang J, Slingerland JM (2003) Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2: 339-345.
28. Stephenson I, Nicholson KG, Gluck R, Mischler R, Newman RW, et al. (2003) Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial. Lancet 362: 1959-1966.
29. Chen YL, Law PY, Loh HH (2005) Inhibition of PI3K/Akt signaling: an emerging paradigm for targeted cancer therapy. Curr Med Chem Anticancer Agents 5: 575-589.
30. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB (2005) Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 4: 988-1004.
31. Kim D, Cheng GZ, Lindsley CW, Yang H, Cheng JQ (2005) Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer. Curr Opin Investig Drugs 6: 1250-1258.
32. Tan J, Hallahan DE (2003) Growth factor-independent activation of protein kinase B contributes to the inherent resistance of vascular endothelium to radiation-induced apoptotic response. Cancer Res 63: 7663-7667.
33. Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132: 27-42.
34. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, et al. (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. Embo J 19: 5720-5728.
35. Feng XZ, Dong M, Gao ZJ, Xu SX (2003) Three new triterpenoid saponins from Ixeris sonchifolia and their cytotoxic activity. Planta Med 69: 1036-1040.
36. Fu GM, Wang YH, Gao S, Tang MJ, Yu SS (2005) Five new cytotoxic triterpenoid saponins from the roots of Symplocos chinensis. Planta Med 71: 666-672.
37. Bockbrader KM, Tan M, Sun Y (2005) A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL-and etoposide-induced apoptosis in breast cancer cells. Oncogene 24: 7381-7388.
38. Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927.
39. Hiron M, Daveau M, Arnaud P, Bauer J, Lebreton JP (1992) The human hepatoma Hep3B cell line as an experimental model in the study of the longterm regulation of acute-phase proteins by cytokines. Biochem J 287 (Pt 1): 255-259.
40. Foster KA, Oster CG, Mayer MM, Avery ML, Audus KL (1998) Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp Cell Res 243: 359-366.